Vaccine News and Research

Latest Vaccine News and Research

Canadian scientists join international battle against Zika virus

The spread of the Zika virus, which can cause devastating birth defects, has become a pressing public health issue in many countries. To this day, there is no vaccine to prevent and no medicine to treat Zika virus infections.

16 Mar 2017

Study shows how mutations allow HCV to elude immune responses and vaccines

Unlike its viral cousins hepatitis A and B, hepatitis C virus (HCV) has eluded the development of a vaccine and infected more than 170 million people worldwide.

16 Mar 2017

Research reveals reasons for adolescents not getting vaccinated against HPV

Concern about sexual activity is declining as a reason parents do not get their daughters the human papillomavirus (HPV) vaccine, according to a research study presented today at the Society of Gynecologic Oncology’s 2017 Annual Meeting on Women’s Cancer.

16 Mar 2017

Research findings advance development of HIV vaccines that induce broadly neutralizing antibodies

A Duke Health-led research team has described both the pathway of HIV protective antibody development and a synthetic HIV outer envelope mimic that has the potential to induce the antibodies with vaccination.

16 Mar 2017

Bacterial cell counting and sizing using the Multisizer

In this interview, Dr. Rich Jones introduces bacterial cell counting and an example of when the Multisizer 4e from Beckman Coulter has been used for this application.

From Beckman Coulter Life Sciences - Particle Counting and Characterization 15 Mar 2017

Study: Investigational Ebola vaccine regimen induced immune response that persisted for one year

A two-vaccine regimen intended to protect against Ebola virus disease induced an immune response that persisted for approximately one year in healthy adult volunteers, according to results from a Phase 1 clinical trial published in the March 14th issue of the Journal of the American Medical Association.

15 Mar 2017

Natural immune molecule shows protective effect against Zika virus in mouse, monkey models

A molecule naturally produced by the immune system protects mice and monkeys against Zika virus infection, an international team of researchers has found.

14 Mar 2017

New study examines immune responses to Ebola vaccines at one year after immunization

Immune responses to Ebola vaccines at one year after vaccination are examined in a new study appearing in the March 14 issue of JAMA.

14 Mar 2017

New method can precisely track replication of yellow fever virus in host immune cells

Researchers from Princeton University's Department of Molecular Biology have developed a new method that can precisely track the replication of yellow fever virus in individual host immune cells.

14 Mar 2017

Study finds vaccines to be successful in preventing pandemic flu

Vaccines are successful in preventing pandemic flu and reducing the number of patients hospitalised as a result of the illness, a study led by academics at The University of Nottingham has found.

13 Mar 2017

Pre-existing immunity to dengue virus modulates T cell response to Zika infection

Although Zika and dengue are considered different virus "species," they are so closely related that the immune system treats Zika just like another version of dengue, report researchers at La Jolla Institute for Allergy and Immunology.

13 Mar 2017

UTHealth researchers receive $1.5 million to increase HPV vaccine rates among minority youth

The Cancer Prevention and Research Institute of Texas has awarded $1.5 million to researchers at The University of Texas Health Science Center at Houston School of Public Health for a project designed to increase human papillomavirus vaccine rates among minority youth in medically underserved areas across Houston.

13 Mar 2017

Georgia State professor receives five-year $4.1 million federal grant to develop drug targeting Ebola virus

Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university's Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a five-year, $4.1 million federal grant to develop a drug targeting Ebola virus.

13 Mar 2017

Investigational RSV vaccine protects cattle from respiratory diseases

A novel vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, protected cattle from respiratory syncytial virus (RSV) infection, according to research published online in npj Vaccines on March 8.

10 Mar 2017

Patients more likely to get vaccinations when physicians make appointments, study finds

You're much more likely to get a flu shot if your doctor makes the appointment for you, Rutgers researchers have discovered.

10 Mar 2017

Study shows how risk perception of flu vaccine differs between white and African American adults

Fewer than half of American adults get vaccinated despite strong recommendations from the Centers for Disease Control and Prevention and widespread availability of free and low-cost vaccines.

10 Mar 2017

GW researchers develop way to test potency of recombinant hookworm vaccines

Researchers at the George Washington University have developed a way to test recombinant vaccines for their ability to stay effective after years of storage.

10 Mar 2017

Pittcon 2017: reflections from the floor

Pittcon 2017 commenced with a fascinating talk by world-renowned optogenetics expert Dr. Karl Deisseroth, D.H. Chen Professor of Bioengineering, Psychiatry and Behavioral Sciences, Stanford University and Investigator of the Howard Hughes Medical Institute.

From Pittcon 9 Mar 2017

Parental concerns about safety, side effects may negatively influence uptake of child flu vaccine

The first study investigating parental attitudes towards the UK's child flu vaccine has found concerns about safety and side effects may negatively influence uptake, and recommends that public health messages need to be reinforced.

8 Mar 2017

UCLA researchers find ways to soften or stiffen up T cells for controlling immune response

T cells, the managers of our immune systems, spend their days shaking hands with another type of cell that presents small pieces of protein from pathogens or cancerous cells to the T cell.

8 Mar 2017

Vaccine News and Research

Latest Vaccine News and Research

Canadian scientists join international battle against Zika virus

Study shows how mutations allow HCV to elude immune responses and vaccines

Research reveals reasons for adolescents not getting vaccinated against HPV

Research findings advance development of HIV vaccines that induce broadly neutralizing antibodies

Bacterial cell counting and sizing using the Multisizer

Study: Investigational Ebola vaccine regimen induced immune response that persisted for one year

Natural immune molecule shows protective effect against Zika virus in mouse, monkey models

New study examines immune responses to Ebola vaccines at one year after immunization

New method can precisely track replication of yellow fever virus in host immune cells

Study finds vaccines to be successful in preventing pandemic flu

Pre-existing immunity to dengue virus modulates T cell response to Zika infection

UTHealth researchers receive $1.5 million to increase HPV vaccine rates among minority youth

Georgia State professor receives five-year $4.1 million federal grant to develop drug targeting Ebola virus

Investigational RSV vaccine protects cattle from respiratory diseases

Patients more likely to get vaccinations when physicians make appointments, study finds

Study shows how risk perception of flu vaccine differs between white and African American adults

GW researchers develop way to test potency of recombinant hookworm vaccines

Pittcon 2017: reflections from the floor

Parental concerns about safety, side effects may negatively influence uptake of child flu vaccine

UCLA researchers find ways to soften or stiffen up T cells for controlling immune response

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Newsletters you may be interested in